GYRE 8-K 2026-07-16

GYRE THERAPEUTICS, INC. (GYRE) 8-K dated 2026-07-16 — accession 0001140361-26-028716. This URL is the filing, not the GYRE hub.

GYRE THERAPEUTICS, INC. (GYRE) is a biotechnology company listed on NASDAQ.

GYRE THERAPEUTICS, INC. filed a 8-K on 2026-07-16. Accession 0001140361-26-028716.

Cached items: 5.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.

Not investment advice. The GYRE SEC hub lists recent forms. The stock page is the research view.